Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

Share Price is delayed by 15 minutes
Get Live Data
3.60    0.00 (0.00%)
Bid:
3.30
Ask:
3.90
Spread: 0.60 (18.182%)
Market Cap: £4.48m
PRIM Live PriceLast checked at - London Stock Exchange

Intraday Primorus Inv. Share Chart

Exercise of Options in Zuuse Limited

15 Sep 2021 07:00

RNS Number : 7847L
Primorus Investments PLC
15 September 2021
 

 

Primorus Investments PLC

 

Exercise of Options in Zuuse Limited

 

Primorus Investments PLC (the "Company"), the AIM listed investment company, is pleased to provide the following update regarding options held in one of its investee companies, Zuuse Limited ("Zuuse").

 

Zuuse is a Melbourne-based construction software vendor with operations in the UK, USA, Australia and New Zealand. Following participation in an investment round in late 2020, Primorus held 2,057,205 ordinary shares in Zuuse along with 1,000,000 options with an exercise price of A$0.50 per option (the "Options").

 

The Company has now exercised the Options for total consideration of A$500,000 (approximately £265,000). Following the exercise, the Company will hold 3,065,058 shares in Zuuse representing approximately 2.42 per cent. of Zuuse's issued share capital.

 

Zuuse performed well during the first half of 2021, with the revenue run-rate increasing to over A$20m at June 2021. This represented an annualised growth rate of 48% for the first half of 2021. In the year ended 31 December 2020, Zuuse reported turnover of A$17,995,000 and made a loss after tax of A$2,999,000.

 

Geoff Tarrant Executive Chairman of Zuuse said "We appreciate the continuing support of the Primorus team and remain optimistic on the outlook for our global business in 2022."

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

 

 

For further information, please contact:

 

Primorus Investments plc +44 (0)20 8154 7909

Matthew Beardmore, Chief Executive Officer

 

Nominated Adviser and Broker

Cairn Financial Advisers LLP +44 (0)20 7213 0880

Sandy Jamieson / James Caithie

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQDGGDCXUBDGBS
Date   Source Headline
19th Jun 20264:15 pmRNSNotice of AGM & Proposed Rule 9 Waiver
12th Jun 20263:36 pmRNSHolding(s) in Company
2nd Jun 20269:35 amRNSFinal Results
24th Apr 20262:00 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:00 amRNSFurther Investment in Fresho Pty Ltd
10th Feb 20267:00 amRNSBoard role changes
15th Jan 20264:38 pmRNSHolding(s) in Company
9th Jan 20267:00 amRNSTransaction in Own Shares & TR1
8th Jan 20267:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
2nd Oct 20257:00 amRNSTransaction in Own Shares
24th Sep 20257:00 amRNSInvestee Company Update - Virtualstock
23rd Sep 20257:00 amRNSHalf-year Report
20th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20252:01 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSTransaction in Own Shares & TR-1
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSHolding(s) in Company
24th Jul 20257:48 amRNSTransaction in Own Shares
18th Jul 20254:12 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSTransaction in Own Shares & TR-1
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 202512:30 pmRNSAnnouncement by Pri0r1ty Intelligence Group PLC
11th Jul 20258:03 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSHolding(s) in Company
10th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20251:35 pmRNSResult of AGM
25th Jun 202510:05 amRNSHoldings in Company
25th Jun 20257:00 amRNSInvestee Company Update - Pri0r1ty
13th Jun 20257:00 amRNSNotice of AGM & Proposed Rule 9 Waiver
30th May 20254:25 pmRNSFinal Results
31st Mar 20257:00 amRNSFurther Investment in Interpac Ltd
20th Jan 202511:00 amRNSDirector/PDMR Shareholding
20th Jan 202511:00 amRNSHolding(s) in Company
23rd Dec 20242:10 pmRNSInvestee Company Update – Alteration Earth
5th Nov 20247:00 amRNSSale Of Engage Shareholding
23rd Oct 202412:10 pmRNSHolding(s) in Company
30th Sep 20247:00 amRNSHolding(s) in Company
27th Sep 20245:05 pmRNSDirector/PDMR Shareholding
20th Sep 20241:10 pmRNSFurther Investment - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.